A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects

NCT01403792 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus

Interventions

DRUG: P2G12

Sponsor

University of Surrey

Collaborators

[object Object]